An investigation for investors in Athersys, Inc. (NASDAQ: ATHX) shares over potential securities laws violations by Athersys was announced and NASDAQ: ATHX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/09/2018 -- Athersys, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Athersys, Inc. (NASDAQ: ATHX), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Athersys, Inc. (NASDAQ: ATHX) concerning whether a series of statements by Athersys, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cleveland, OH based Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Athersys, Inc. reported that its annual Total Revenue declined from $17.34 million in 2016 to $3.7 million in 2017 and that its Net Loss increased from $15.02 million in 2016 to $33.28 million in 2017.
Those who purchased shares of Athersys, Inc. (NASDAQ: ATHX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels